125 related articles for article (PubMed ID: 8543564)
1. Effects of protein tyrosine kinase inhibitors with different modes of action on topoisomerase activity and death of IL-2-dependent CTLL-2 cells.
Azuma Y; Onishi Y; Sato Y; Kizaki H
J Biochem; 1995 Aug; 118(2):312-8. PubMed ID: 8543564
[TBL] [Abstract][Full Text] [Related]
2. Early effects of protein kinase modulators on DNA synthesis in rat cerebral cortex.
Yakisich JS; Sidén A; Vargas VI; Eneroth P; Cruz M
Exp Neurol; 1999 Sep; 159(1):164-76. PubMed ID: 10486185
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.
Markovits J; Linassier C; Fossé P; Couprie J; Pierre J; Jacquemin-Sablon A; Saucier JM; Le Pecq JB; Larsen AK
Cancer Res; 1989 Sep; 49(18):5111-7. PubMed ID: 2548712
[TBL] [Abstract][Full Text] [Related]
4. Induction of mouse thymocyte apoptosis by inhibitors of tyrosine kinases is associated with dephosphorylation of nuclear proteins.
Azuma Y; Onishi Y; Sato Y; Kizaki H
Cell Immunol; 1993 Nov; 152(1):271-8. PubMed ID: 8242767
[TBL] [Abstract][Full Text] [Related]
5. Regulation of apoptosis of interleukin 2-dependent mouse T-cell line by protein tyrosine phosphorylation and polyamines.
Min A; Hasuma T; Yano Y; Matsui-Yuasa I; Otani S
J Cell Physiol; 1995 Dec; 165(3):615-23. PubMed ID: 7593241
[TBL] [Abstract][Full Text] [Related]
6. Effects of tyrosine kinase inhibitors on cell death induced by sodium fluoride and pertussis toxin in the pancreatic beta-cell line, RINm5F.
Elliott J; Scarpello JH; Morgan NG
Br J Pharmacol; 2001 Jan; 132(1):119-26. PubMed ID: 11156568
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
Bergamaschi G; Rosti V; Danova M; Ponchio L; Lucotti C; Cazzola M
Leukemia; 1993 Dec; 7(12):2012-8. PubMed ID: 8255101
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives.
Markovits J; Larsen AK; Ségal-Bendirdjian E; Fossé P; Saucier JM; Gazit A; Levitzki A; Umezawa K; Jacquemin-Sablon A
Biochem Pharmacol; 1994 Aug; 48(3):549-60. PubMed ID: 8068042
[TBL] [Abstract][Full Text] [Related]
9. Staurosporine-induced thymocyte apoptosis is inhibited by herbimycin A, a specific inhibitor of protein tyrosine kinase.
Azuma Y; Onishi Y; Hirata C; Tanimoto Y; Yamada T; Kizaki H
Biochem Mol Biol Int; 1995 Nov; 37(4):635-43. PubMed ID: 8589636
[TBL] [Abstract][Full Text] [Related]
10. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells.
Okura A; Arakawa H; Oka H; Yoshinari T; Monden Y
Biochem Biophys Res Commun; 1988 Nov; 157(1):183-9. PubMed ID: 2848517
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
Shimokado K; Umezawa K; Ogata J
Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
[TBL] [Abstract][Full Text] [Related]
12. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
Leduc I; Haddad P; Giasson E; Meloche S
Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882
[TBL] [Abstract][Full Text] [Related]
13. Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II.
McCabe MJ; Orrenius S
Biochem Biophys Res Commun; 1993 Jul; 194(2):944-50. PubMed ID: 8393675
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of dexamethasone-induced apoptosis in rat thymocytes by herbimycin A.
Lee E; Miura M; Yoshinari M; Iwai H; Kariya K
Biochem Biophys Res Commun; 1994 Jul; 202(1):128-34. PubMed ID: 8037703
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mouse preimplantation development: inhibitory effect of genistein, an inhibitor of tyrosine protein phosphorylation, on cleavage of one-cell embryos.
Besterman B; Schultz RM
J Exp Zool; 1990 Oct; 256(1):44-53. PubMed ID: 2401883
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
17. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
18. Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
Ma YC; Wang ZX; Jin SJ; Zhang YX; Hu GQ; Cui DT; Wang JS; Wang M; Wang FQ; Zhao ZJ
PLoS One; 2016; 11(10):e0162821. PubMed ID: 27760157
[TBL] [Abstract][Full Text] [Related]
19. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
Huang YT; Hwang JJ; Lee PP; Ke FC; Huang JH; Huang CJ; Kandaswami C; Middleton E; Lee MT
Br J Pharmacol; 1999 Nov; 128(5):999-1010. PubMed ID: 10556937
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.
Lei W; Mayotte JE; Levitt ML
Anticancer Res; 1999; 19(1A):221-8. PubMed ID: 10226546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
